Chagas Disease Prevalence in a Cohort of Neurocysticercosis Patients in a Nonendemic Setting.

McAleese, Katherine R; Guzmán, Janitzio J; Thumm, Lauren; Nutman, Thomas B; Showler, Adrienne; O'Connell, Elise M · Clin Infect Dis · 2022

retrospective_cohort · Level III

Where this comes from

Abstract

In a cohort of mostly Central American immigrants with confirmed neurocysticercosis (NCC), 3.1% were confirmed positive for Chagas disease (CD). The majority were diagnosed with NCC before age 50. Entry to care for NCC is an opportunity for early detection and possible treatment for CD in those from endemic areas.

Medical subject headings